Eric Schoenmakers

Dr. Eric Schoenmakers is an Equity Research Senior Analyst at Point Sur Investors LLC.
Dr. Schoenmakers worked as an independent consultant providing services across his wide spectrum of expertise, including Preclinical R&D, Translational Medicine, Biomarker and CDx Development, and GxP/Quality Management.
Before that he served as a Director Clinical Genetics within the Translational Medicine team at Pharmacyclics, Inc. Prior to joining Pharmacyclics, he headed the Pfizer Oncology Clinical Research Laboratory at Pfizer’s Global R&D site in La Jolla, CA.
He started his career in academia, and was a tenured faculty member at the Department of Human Genetics in Nijmegen, The Netherlands for over a decade.
He earned a MSc.
in Biology (with majors in Molecular Biology, Genetics, and Immunology) at the University of Nijmegen, The Netherlands, and a summa cum laude doctorate in Human (Cancer) Genetics from the University of Leuven, Belgium.